Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9875
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRoberts, Fiona Oen
dc.contributor.authorGunawardana, Dishan Hen
dc.contributor.authorPathmaraj, Kunthien
dc.contributor.authorWallace, Anthonyen
dc.contributor.authorU, Paul Len
dc.contributor.authorMi, Tianen
dc.contributor.authorBerlangieri, Salvatore Uen
dc.contributor.authorO'Keefe, Graeme Jen
dc.contributor.authorRowe, Christopher Cen
dc.contributor.authorScott, Andrew Men
dc.date.accessioned2015-05-15T23:08:46Z
dc.date.available2015-05-15T23:08:46Z
dc.date.issued2005-03-01en
dc.identifier.citationJournal of Nuclear Medicine Technology; 33(1): 44-7en
dc.identifier.govdoc15731021en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/9875en
dc.description.abstractThe use of PET in Australia has grown rapidly. We conducted a prospective study of the radiation exposure of technologists working in PET and evaluated the occupational radiation dose after implementation of strategies to lower exposure.Radiation doses measured by thermoluminescent dosimeters over a 2-y period were reviewed both for technologists working in PET and for technologists working in general nuclear medicine in a busy academic nuclear medicine department. The separate components of the procedures for dose administration and patient monitoring were assessed to identify the areas contributing the most to the dose received. The impact on dose of implementing portable 511-keV syringe shields (primary shields) and larger trolley-mounted shields (secondary shields) was also compared with initial results using no shield.We found that the radiation exposure of PET technologists was higher than that of technologists performing general nuclear medicine studies, with doses averaging 771 +/- 147 and 524 +/- 123 microSv per quarter, respectively (P = 0.01). The estimated dose per PET procedure was 4.1 microSv (11 nSv/MBq). Injection of 18F-FDG contributed the most to radiation exposure. The 511-keV syringe shield reduced the average dose per injection from 2.5 to 1.4 microSv (P < 0.001). For the longer period of dose transportation and injection, the additional use of the secondary shield resulted in a significantly lower dose of radiation than did use of the primary shield alone or no shield (1.9 vs. 3.6 microSv [P = 0.01] and 3.4 microSv [P = 0.03], respectively).The radiation doses currently received by technologists working in PET are within accepted occupational health guidelines, but improved shielding can further reduce the dose.en
dc.language.isoenen
dc.subject.otherAustralia.epidemiologyen
dc.subject.otherHumansen
dc.subject.otherNuclear Medicine Department, Hospital.statistics & numerical dataen
dc.subject.otherOccupational Exposure.analysis.prevention & control.statistics & numerical dataen
dc.subject.otherPositron-Emission Tomography.statistics & numerical dataen
dc.subject.otherRadiation Dosageen
dc.subject.otherRadiation Injuries.prevention & controlen
dc.subject.otherRadiation Monitoring.methodsen
dc.subject.otherRadiation Protection.methodsen
dc.subject.otherRisk Assessment.methodsen
dc.subject.otherRisk Factorsen
dc.subject.otherThermoluminescent Dosimetry.statistics & numerical dataen
dc.titleRadiation dose to PET technologists and strategies to lower occupational exposure.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of nuclear medicine technologyen
dc.identifier.affiliationDepartment of Nuclear Medicine and Centre for PET, Austin Hospital, Melbourne, Australiaen
dc.description.pages44-7en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/15731021en
dc.type.austinJournal Articleen
local.name.researcherBerlangieri, Salvatore U
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptClinical Haematology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

50
checked on Dec 24, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.